Denali Advisors’s Tourmaline Bio TRML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,600
Closed -$128K 441
2024
Q1
$128K Buy
+5,600
New +$197K 0.04% 261

Other funds holding TRML

Denali Advisors's TRML Position: Q2 2024 in Review

Denali Advisors sold out of Tourmaline Bio (TRML) in Q2 2024, closing a stake of 5,600 shares — an estimated $128K sold.

Denali Advisors first reported a position in TRML in Q1 2024 and held it in 1 quarter. The position peaked at $128K in Q1 2024. 84 funds tracked by Wall St. Rank hold TRML as of Q2 2024.

  • Denali Advisors reported no remaining Tourmaline Bio position as of Q2 2024 after selling out during the quarter.
  • Denali Advisors sold 5,600 Tourmaline Bio shares in Q2 2024, an estimated $128K.
  • Denali Advisors first reported a position in Tourmaline Bio in Q1 2024 and held it in 1 quarter.
  • Denali Advisors's Tourmaline Bio position peaked at $128K in Q1 2024.
  • 84 funds tracked by Wall St. Rank held Tourmaline Bio as of Q2 2024.

Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.